Article Text

Download PDFPDF
Successful treatment of genital ulcers with infliximab in Behçet’s disease
  1. G Haugeberg1,
  2. M Velken2,
  3. V Johnsen1
  1. 1Department of Rheumatology, Sørlandet Hospital, Serviceboks 416, N-4604 Kristiansand S, Norway
  2. 2Department of Gynaecology, Sørlandet Hospital, Serviceboks 416, N-4604 Kristiansand S, Norway
  1. Correspondence to:
    Dr G Haugeberg
    glennhaugebergoperamail.com or glenn.haugebergsshf.no

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Recurrent oral and genital aphthous ulcerations are the hallmarks of Behçet’s disease. Up to now the various clinical manifestations in Behçet’s disease have been treated with limited success. Recently, clinical observations have reported dramatic responses on clinical signs and symptoms in patients treated with tumour necrosis factor α (TNFα) blocking drugs, including severe mucocutaneous,1–3 gastrointestinal4,5 and ocular manifestations.6

We report the successful treatment with infliximab of a severe longstanding genital ulcer in a patient with Behçet’s disease.

CASE REPORT

The patient was a 29 year old woman with Behçet’s disease who had had recurrent oral ulcers from age 5 and genital ulcers, arthralgia, and uveitis from age 23. The outbreaks of uveitis were treated with local administration of dexamethasone only. From autumn 2000 the severity of the genital manifestations increased, and treatment with colchicine and prednisolone was started. However, during follow up she still had painful …

View Full Text